Logo image of 1MDLZ.MI

MONDELEZ INTERNATIONAL INC-A (1MDLZ.MI) Stock Fundamental Analysis

BIT:1MDLZ - Euronext Milan - US6092071058 - Common Stock - Currency: EUR

59.98  +0.6 (+1.01%)

Fundamental Rating

5

1MDLZ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Food Products industry. While 1MDLZ has a great profitability rating, there are some minor concerns on its financial health. 1MDLZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

1MDLZ had positive earnings in the past year.
1MDLZ had a positive operating cash flow in the past year.
Each year in the past 5 years 1MDLZ has been profitable.
Each year in the past 5 years 1MDLZ had a positive operating cash flow.
1MDLZ.MI Yearly Net Income VS EBIT VS OCF VS FCF1MDLZ.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

1MDLZ has a Return On Assets of 6.73%. This is in the better half of the industry: 1MDLZ outperforms 74.14% of its industry peers.
1MDLZ has a better Return On Equity (17.12%) than 84.48% of its industry peers.
1MDLZ's Return On Invested Capital of 10.27% is amongst the best of the industry. 1MDLZ outperforms 84.48% of its industry peers.
1MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is in line with the industry average of 7.19%.
The 3 year average ROIC (7.83%) for 1MDLZ is below the current ROIC(10.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.73%
ROE 17.12%
ROIC 10.27%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1MDLZ.MI Yearly ROA, ROE, ROIC1MDLZ.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

1MDLZ has a better Profit Margin (12.65%) than 86.21% of its industry peers.
1MDLZ's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 18.37%, 1MDLZ belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
1MDLZ's Operating Margin has improved in the last couple of years.
1MDLZ has a Gross Margin (39.12%) which is in line with its industry peers.
1MDLZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.37%
PM (TTM) 12.65%
GM 39.12%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
1MDLZ.MI Yearly Profit, Operating, Gross Margins1MDLZ.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1MDLZ is creating some value.
The number of shares outstanding for 1MDLZ has been reduced compared to 1 year ago.
1MDLZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1MDLZ has an improved debt to assets ratio.
1MDLZ.MI Yearly Shares Outstanding1MDLZ.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
1MDLZ.MI Yearly Total Debt VS Total Assets1MDLZ.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1MDLZ has an Altman-Z score of 2.76. This is not the best score and indicates that 1MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
1MDLZ's Altman-Z score of 2.76 is fine compared to the rest of the industry. 1MDLZ outperforms 70.69% of its industry peers.
1MDLZ has a debt to FCF ratio of 5.04. This is a neutral value as 1MDLZ would need 5.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.04, 1MDLZ is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
A Debt/Equity ratio of 0.58 indicates that 1MDLZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, 1MDLZ is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.04
Altman-Z 2.76
ROIC/WACC1.32
WACC7.77%
1MDLZ.MI Yearly LT Debt VS Equity VS FCF1MDLZ.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.68 indicates that 1MDLZ may have some problems paying its short term obligations.
1MDLZ has a worse Current ratio (0.68) than 87.93% of its industry peers.
A Quick Ratio of 0.48 indicates that 1MDLZ may have some problems paying its short term obligations.
1MDLZ has a Quick ratio of 0.48. This is in the lower half of the industry: 1MDLZ underperforms 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.48
1MDLZ.MI Yearly Current Assets VS Current Liabilites1MDLZ.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.23% over the past year.
Measured over the past 5 years, 1MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
1MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 1.18%.
Measured over the past years, 1MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)4.23%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.62%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%3.11%

3.2 Future

The Earnings Per Share is expected to grow by 4.43% on average over the next years.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y-13.83%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
EPS Next 5Y4.43%
Revenue Next Year2.97%
Revenue Next 2Y3.63%
Revenue Next 3Y3.82%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1MDLZ.MI Yearly Revenue VS Estimates1MDLZ.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1MDLZ.MI Yearly EPS VS Estimates1MDLZ.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.73, the valuation of 1MDLZ can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as 1MDLZ.
When comparing the Price/Earnings ratio of 1MDLZ to the average of the S&P500 Index (28.87), we can say 1MDLZ is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 22.92, the valuation of 1MDLZ can be described as rather expensive.
Based on the Price/Forward Earnings ratio, 1MDLZ is valued a bit more expensive than the industry average as 65.52% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 21.38. 1MDLZ is around the same levels.
Industry RankSector Rank
PE 19.73
Fwd PE 22.92
1MDLZ.MI Price Earnings VS Forward Price Earnings1MDLZ.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1MDLZ is valued a bit more expensive than 70.69% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1MDLZ is valued a bit more expensive than the industry average as 60.34% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 25.05
EV/EBITDA 13.08
1MDLZ.MI Per share data1MDLZ.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The excellent profitability rating of 1MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.85
EPS Next 2Y-2.33%
EPS Next 3Y1.52%

4

5. Dividend

5.1 Amount

1MDLZ has a Yearly Dividend Yield of 2.87%.
Compared to an average industry Dividend Yield of 3.09, 1MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.46, 1MDLZ has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

On average, the dividend of 1MDLZ grows each year by 10.52%, which is quite nice.
Dividend Growth(5Y)10.52%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1MDLZ pays out 50.94% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of 1MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.94%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
1MDLZ.MI Yearly Income VS Free CF VS Dividend1MDLZ.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
1MDLZ.MI Dividend Payout.1MDLZ.MI Dividend Payout, showing the Payout Ratio.1MDLZ.MI Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

BIT:1MDLZ (4/22/2025, 7:00:00 PM)

59.98

+0.6 (+1.01%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners85.54%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap77.71B
Analysts76
Price Target62.17 (3.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend1.55
Dividend Growth(5Y)10.52%
DP50.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.6%
Min EPS beat(2)-3.07%
Max EPS beat(2)14.26%
EPS beat(4)3
Avg EPS beat(4)5.8%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)6.14%
EPS beat(12)11
Avg EPS beat(12)5.85%
EPS beat(16)12
Avg EPS beat(16)4.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.99%
Revenue beat(4)0
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.6%
Revenue beat(8)3
Avg Revenue beat(8)-0.17%
Revenue beat(12)7
Avg Revenue beat(12)0.95%
Revenue beat(16)10
Avg Revenue beat(16)0.83%
PT rev (1m)-4.26%
PT rev (3m)-18.71%
EPS NQ rev (1m)-1.53%
EPS NQ rev (3m)-21.99%
EPS NY rev (1m)0.47%
EPS NY rev (3m)-14.41%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-3.5%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 19.73
Fwd PE 22.92
P/S 2.42
P/FCF 25.05
P/OCF 17.98
P/B 3.28
P/tB N/A
EV/EBITDA 13.08
EPS(TTM)3.04
EY5.07%
EPS(NY)2.62
Fwd EY4.36%
FCF(TTM)2.39
FCFY3.99%
OCF(TTM)3.34
OCFY5.56%
SpS24.76
BVpS18.3
TBVpS-10.15
PEG (NY)N/A
PEG (5Y)2.85
Profitability
Industry RankSector Rank
ROA 6.73%
ROE 17.12%
ROCE 13.68%
ROIC 10.27%
ROICexc 10.56%
ROICexgc 86.77%
OM 18.37%
PM (TTM) 12.65%
GM 39.12%
FCFM 9.67%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.04
Debt/EBITDA 1.97
Cap/Depr 106.53%
Cap/Sales 3.81%
Interest Coverage 12.09
Cash Conversion 61.39%
Profit Quality 76.4%
Current Ratio 0.68
Quick Ratio 0.48
Altman-Z 2.76
F-Score8
WACC7.77%
ROIC/WACC1.32
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)4.23%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.62%
EPS Next Y-13.83%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
EPS Next 5Y4.43%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%3.11%
Revenue Next Year2.97%
Revenue Next 2Y3.63%
Revenue Next 3Y3.82%
Revenue Next 5Y3.62%
EBIT growth 1Y17.29%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year7.92%
EBIT Next 3Y7.96%
EBIT Next 5Y8.23%
FCF growth 1Y-2.19%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y4.16%
OCF growth 3Y5.84%
OCF growth 5Y4.37%